<DOC>
	<DOCNO>NCT01119742</DOCNO>
	<brief_summary>To demonstrate comparable safety efficacy Taro Pharmaceuticals , Inc butenafine hydrochloride cream 1 % test product Lotrimin Ultra cream ( reference list drug ) treatment interdigital tinea pedis , show superiority active treatment placebo ( vehicle ) .</brief_summary>
	<brief_title>Clinical Equivalence Two Generic Butenafine Hydrochloride 1 % Creams Compared Lotrimin Ultra Cream Patients With Interdigital Tinea Pedis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Butenafine</mesh_term>
	<mesh_term>Clotrimazole</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>1 . Male nonpregnant , non lactate female 18 year age old . 2 . Signed informed consent form , meet criteria current FDA regulation requirement India regulatory authority . 3 . If female child bear potential , negative urine pregnancy test baseline visit , 4 . A total score least six ( 6 ) follow eight ( 8 ) clinical sign symptom interdigital tinea pedis : fissuring , erythema , maceration , vesiculation , desquamation/scaling , exudation , pruritus , burning/stinging . In addition infected area must minimum score least 2 erythema minimum score least 2 either pruritus desquamation/scaling 5 . A confirmed clinical diagnosis interdigital tinea pedis . 6 . The presence tinea pedis infection , confirm observation segment fungal hypha microscopic KOH wet mount examination ( potassium hydroxide mount preparation ) . 7 . Identification appropriate dermatophyte culture send central laboratory . The appropriate dermatophytes Trichophyton rubrum , Trichophyton mentagrophytes Epidermophyton floccosum . 1 . Use follow within indicated timeline : Oral injectable steroid within four week study start . Any oral antifungal within 4 week study start . Use topical corticosteroid topical antipruritic foot within 72 hour study start . Any prescription OTC topical antifungal foot within two week prior study entry . Use antihistamine within 72 hour study start . 2 . Any known hypersensitivity butenafine antifungal agent . 3 . Evidence concurrent dermatophytic infection toe nail ( onychomycosis ) dermatological condition foot may interfere Investigators evaluation tinea pedis . 4 . Patients recurrent tinea pedis ( 3 infection past 12 month ) unresponsive previous antifungal therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Tinea Pedis</keyword>
	<keyword>Interdigital</keyword>
</DOC>